|Day Low/High||238.24 / 251.60|
|52 Wk Low/High||187.72 / 306.71|
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
I have been among the most wary of China and its ability to change. I remain that way. But the U.S. got more than I ever thought.
One concern for traders and investors would be that the good cheer created by the development of this Phase One deal, as well as actions taken by the FOMC, are nearing or at the point where the headline risk points in the other direction.
Earnings reports are solid but this overbought market is looking for a good reason to consolidate a big move.
The big tech names are once again surging, and as long as they keep their noses clean, that should continue.
This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.
Despite fluff and puff of UNH's analysts' day, little here screams for getting in right now.
There is no doubt in my mind that the firm is executing at a high level.
Time to review the charts and indicators.
UnitedHealth Group and JPMorgan are both bucking other trends to rise as more moderate leanings start to dominate the Democratic horse race.
Prices have rocketed higher since early October.
These are the 10 reasons why we keep going up, despite all the bad news.
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
After seeing the idea raised -- and derided -- I found that the Dow has been over 27,000 twice this year and each time it did this....
I have the answer behind the conundrum that forces stocks up that should be going lower.
These stocks's earnings were 'not as bad as feared,' and here are some more names that pushed the NABAF narrative.
There are plenty of senior growth companies that can still move higher.
The Fed is doing this right. Let me repeat... the Fed is not screwing this up.
As mentioned earlier, breadth was only 2-1 positive with UnitedHealth , JPMorgan and Johnson & Johnson responsible for a large portion of the market's gains. Bond yields rose, aiding the rate-sensitive banks (who generally met expectations). FANG ha...
"Only" about 2-1 advancers over decliners as UnitedHealth Care , JP Morgan and Johnson & Johnson account for a disproportionate amount of the market's rally.
Citigroup and Lululemon are on the radar this morning.
These three CEFs are particularly appealing right now, with overhyped fears making them unusually cheap.
Quintessential investor Graham described the stock market in the short term as an imperfect voting machine.
Let's get the charts and indicators in for a check up.
The impact of Elizabeth Warren is pretty much everywhere Thursday.
What the Fed needs to do in July is to cut the FFR by 25 basis points and put the balance sheet management (QT) program to bed two months early.